#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Juvenile psoriatic arthritis Synovitis Drug eruption Hyperphagia Noonan syndrome Pyoderma gangrenosum Leukaemia Follicular lymphoma stage III Intracranial germ cell tumour Biliary neoplasm Stress cardiomyopathy Glomerulonephritis Type IIa hyperlipidaemia Myelodysplastic syndrome Anti-myelin-associated glycoprotein antibodies positive More trials…

    Learn about Rare Diseases

    Testicular leiomyosarcoma Nephroblastoma – Diagnostics Medulloblastoma recurrent – Life with Disease Pulmonary fibrosis – Trials in Disease Haemolytic uraemic syndrome – Life with Disease Myelodysplastic syndrome with excess blasts – Life with Disease Acquired haemophilia – Trials in Disease Mantle cell lymphoma – Basic Information Chordoma – Basic Information Chondrosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glycopyrronium Bromide Trametinib Dimethyl Sulfoxide ANOC-001 Difelikefalin Gen1047 Piracetam Aliskiren Gozetotide Alf-18 MB-CART2219.1 Kan-101 Clofutriben Dermatophagoides Farinae [18F]CPFPX Efinopegdutide Amiloride Pralatrexate Gimeracil ATIGOTATUG Ltp001 Sonelokimab More therapies…

    Learn about Your Condition

    Chronic kidney disease Plasma cell myeloma refractory Microscopic polyangiitis Solitary fibrous tumour Laryngeal leukoplakia Immune thrombocytopenia Coronary artery bypass Immune-mediated enterocolitis Embolic stroke Arterial stiffness Cutaneous lupus erythematosus Sarcoidosis Extra-osseous Ewing's sarcoma Follicular lymphoma Follicular lymphoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Long-Term Safety of Sacituzumab Govitecan for Patients with Metastatic Solid Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Sacituzumab Govitecan
    Belgium France Spain

  • Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Obicetrapib
    Bulgaria Croatia Czechia Denmark Finland Germany +7

  • Study on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dry eye
    • Sjogren’s syndrome
    Investigated Drugs:
    • Lamivudine
    • Emtricitabine
    • Entecavir
    Austria Belgium Bulgaria Czechia France Germany +10

  • Study on Ruxolitinib and Drug Combination for Critically Ill Adults with Acquired Hemophagocytic Syndrome

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Betamethasone Sodium Phosphate Ph. Eur
    • Etoposide
    • Lidocaine Hydrochloride Monohydrate
    France

  • Study Comparing Zimberelimab and Domvanalimab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Domvanalimab
    • Zimberelimab
    • Pembrolizumab
    France Greece Ireland Spain

  • Study on Long-term Safety and Effectiveness of Bimatoprost SR for Patients with Open-angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ocular hypertension
    • Open angle glaucoma
    Investigated Drugs:
    • Bimatoprost
    France Germany Poland Spain
Previous Page
1 … 1,668 1,669 1,670 1,671 1,672 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!